SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

AGHAZADEH TABRIZI, Mojgan
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.345
AS - Asia 5.084
EU - Europa 5.001
SA - Sud America 962
AF - Africa 118
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 9
Totale 23.529
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.115
DE - Germania 2.045
SG - Singapore 1.869
CN - Cina 1.635
BR - Brasile 819
UA - Ucraina 642
RU - Federazione Russa 531
TR - Turchia 495
HK - Hong Kong 481
GB - Regno Unito 445
IT - Italia 408
VN - Vietnam 285
FI - Finlandia 260
SE - Svezia 260
CA - Canada 116
PL - Polonia 113
FR - Francia 98
MX - Messico 93
AR - Argentina 72
IN - India 64
ZA - Sudafrica 56
BD - Bangladesh 47
BE - Belgio 42
JP - Giappone 39
ID - Indonesia 28
ES - Italia 27
IQ - Iraq 27
NL - Olanda 26
CZ - Repubblica Ceca 22
LT - Lituania 22
PK - Pakistan 17
MA - Marocco 16
AE - Emirati Arabi Uniti 14
UZ - Uzbekistan 14
CO - Colombia 13
EC - Ecuador 13
AT - Austria 11
CL - Cile 11
EG - Egitto 11
KE - Kenya 11
KR - Corea 11
IL - Israele 10
AU - Australia 9
UY - Uruguay 9
VE - Venezuela 9
NP - Nepal 8
EU - Europa 7
PY - Paraguay 7
DZ - Algeria 6
PE - Perù 6
RO - Romania 6
SA - Arabia Saudita 6
TN - Tunisia 6
BG - Bulgaria 5
AZ - Azerbaigian 4
IE - Irlanda 4
IR - Iran 4
KZ - Kazakistan 4
MK - Macedonia 4
PT - Portogallo 4
TW - Taiwan 4
AL - Albania 3
BH - Bahrain 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
GR - Grecia 3
GT - Guatemala 3
LV - Lettonia 3
TH - Thailandia 3
BO - Bolivia 2
CG - Congo 2
CI - Costa d'Avorio 2
ET - Etiopia 2
HN - Honduras 2
JM - Giamaica 2
KG - Kirghizistan 2
MN - Mongolia 2
MT - Malta 2
PA - Panama 2
RS - Serbia 2
SN - Senegal 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
BY - Bielorussia 1
CR - Costa Rica 1
DK - Danimarca 1
DM - Dominica 1
EE - Estonia 1
GA - Gabon 1
GL - Groenlandia 1
GP - Guadalupe 1
GY - Guiana 1
HU - Ungheria 1
JO - Giordania 1
KH - Cambogia 1
Totale 23.516
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.266
Fairfield 1.203
Singapore 1.169
Ashburn 1.066
Dallas 954
Houston 749
Jacksonville 698
Ann Arbor 684
Chandler 574
Beijing 520
Seattle 506
Wilmington 496
Santa Clara 487
Hong Kong 475
Cambridge 393
Izmir 220
Los Angeles 197
Nanjing 185
Munich 176
Ferrara 154
Princeton 145
Boardman 142
New York 120
San Diego 111
Warsaw 98
Shanghai 96
Ho Chi Minh City 92
Milan 88
São Paulo 76
Bremen 74
London 70
Helsinki 68
Hefei 65
Shenyang 61
Nanchang 59
Mexico City 57
Turku 56
Changsha 49
Hanoi 49
Tianjin 48
Hebei 44
San Mateo 43
Montreal 41
Brooklyn 40
Orem 40
Brussels 38
Falkenstein 38
Jiaxing 38
Chicago 37
Tokyo 36
Atlanta 34
Johannesburg 34
Frankfurt am Main 32
Denver 31
Dong Ket 29
Falls Church 29
Dearborn 28
Moscow 28
Stockholm 28
Toronto 28
Jinan 27
Philadelphia 27
Phoenix 27
Redwood City 25
Poplar 24
Rio de Janeiro 24
Zhengzhou 23
Buffalo 22
Chennai 22
Mountain View 22
Addison 21
Boston 21
Guangzhou 21
Brasília 20
Kunming 20
San Francisco 20
The Dalles 20
Belo Horizonte 19
Curitiba 17
Ankara 16
Manchester 16
Amsterdam 15
Brno 15
Columbus 15
Orange 15
Auburn Hills 14
Bexley 14
Hangzhou 14
Indiana 14
Jakarta 14
Washington 14
Haiphong 13
San Jose 13
Ningbo 12
Norwalk 12
Baghdad 11
Des Moines 11
Guarulhos 11
Tappahannock 11
Bari 10
Totale 15.194
Salva come PNG Salva come JPEG
Nome #
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists 1.175
Handbook of Cannabis and Related Pathologies 304
A glance at adenosine receptors: Novel target for antitumor therapy 267
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists 261
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 242
A [3+2] nitrile oxide intermolecular cycloaddition approach to 4,5-dihydro-3(2H)-furanone and 3(2H)-furanone ring systems: application to the formal synthesis of (±)-ascofuranone and geiparvarin. 240
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 238
A3 adenosine receptor antagonists: History and future perspectives 236
A synthetic approach for the preparation of rigid analogs of 1,3-dipropyl-7-methyl-8-aryl/heteroarylstyryl xanthines 234
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 234
7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: A promising approach for treating pain and inflammation 228
Design and Synthesis of Potent in Vitro and in Vivo Anticancer Agents Based on 1-(3’,4’,5’-Trimethoxyphenyl)-2-Aryl-1H-Imidazole 223
Allosteric modulators for the A1-adenosine receptor 220
The A3 adenosine receptor: history and perspectives 219
Adenosine receptors and human melanoma 218
Design, synthesis, DNA binding, and biological evaluation of water-soluble hybrid molecules containing two pyrazole analogues of the alkylating cyclopropylpyrroloindole (CPI) subunit of the antitumor agent CC-1065 and polypyrrole minor groove binders 217
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 216
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. 215
Design, synthesis and in vitro cytotoxicity of a cis-dichloroplatinum(II) complex linked to the minor groove binder stallimycin 212
DNA minor groove binders as potential antitumor and antimicrobial agents 211
Synthesis and biological effects of a new series of 2-amino-3-benzoylthiophenes as allosteric enhancers of A1-adenosine receptor 209
New 2-heterocyclyl-imidazo[2,1- i ]purin-5-one derivatives as potent and selective human A 3 adenosine receptor antagonists 209
Allosteric enhancers for A(1) adenosine receptor 207
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 206
Adenosine Receptor Antagonists: Translating Medicinal Chemistry and Pharmacology into Clinical Utility 204
Pyrazole phenylcyclohexylcarbamates as inhibitors of human fatty acid amide hydrolases (FAAH) 201
Blockade of A2A receptors plus L-DOPA after nigrostriatal lesion results in GAD67 mRNA changes different from L-DOPA alone in the rat globus pallidus and substantia nigra reticulata 200
Synthesis and biological evaluation of 2-and 3-aminobenzo[b]thiophene derivatives as antimitotic agents and inhibitors of tubulin polymerization 199
[H-3]-MRE 2029-F20, a selective antagonist radioligand for the human A(2B) adenosine receptors 199
Novel 8-heterocyclyl xanthine derivatives in drug development - An update 197
Pyrazolo [4,3-e][1,2,4]triazolo[1,5-c]pyrimidine template: Organic and medicinal chemistry approach 196
Synthesis and preliminary biological evaluation of new anti-tubulin agents containing different benzoheterocycles 196
Hybrid molecules between distamycin A and active moieties of antitumor agents 194
From tyrosine to glycine: Synthesis and biological activity of potent antagonists of the purinergic P2X(7) receptor 193
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 192
Hybrid molecules based on distamycin A as potential antitumor agents 192
Geiparvarin analogs. 2. Synthesis and cytostatic activity of 5-(4-arylbutadienyl)-3(2H)-furanones and of N-substituted 3-(4-oxo-2-furanyl)-2-buten-2-yl carbamates. 191
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2 191
Discovery and Optimization of a Series of 2-Aryl-4-Amino-5-(3 ',4 ',5 '-trimethoxybenzoyl)Thiazoles as Novel Anticancer Agents 191
Synthesis and biological evaluation of 2-(3 ',4 ',5 '-trimethoxybenzoyl)-3-amino 5-aryl thiophenes as a new class of tubulin inhibitors 188
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 187
Structure-activity relationship studies of a new series of imidazo[2,1-f] purinones as potent and selective A3 adenosine receptor antagonists 186
Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines and linked Heterocycles as template for the adenosine receptor antagonism: Medicinal chemistry approach and sar considerations 185
Design, synthesis and growth inhibition activity of bis-epoxyethyl derivatives of stallimycin modified on the amidino moiety 182
Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease 182
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors 182
Synthesis of a new series of pyrazolo[1,5-a]pyrimidines structurally related to zaleplon 180
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists 180
Synthesis and Biological Evaluation of Novel Allosteric Enhancers of the A1 Adenosine Receptor Based on 2-Amino-3-(4’-Chlorobenzoyl)-4-Substituted-5-Arylethynyl Thiophene 180
Geiparvarin Analogs. 3. Synthesis and cytostatic activity of 3(2H)-furanone and 4,5-dihydro-3(2H)-furanone congeners of geiparvarin, containing a geraniol-like fragment in the side chain 179
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 178
Synthesis of conformationally constrained analogues of KN62, a potent antagonist of the P2X7-receptor 177
Microwave-assisted synthesis of thieno[2,3-c]pyridine derivatives as a new series of allosteric enhancers at the adenosine A(1) receptor 177
Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxyphenylsulfonyl)-5-aryl thiophenes as a new class of antitubulin agents 176
Biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptors 176
Structure-activity relationships around the KN-62, a potent antagonist of the P2X(7)receptor 173
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[(4- arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. Effect of the 5-modification on allosteric enhancer activity at the A1 adenosine receptor 172
Synthesis and Biological Evaluation of 1-Methyl-2-(3’,4’,5’-Trimethoxybenzoyl)-3-Amino Indoles as a New Class of Antimitotic Agents and Tubulin Inhibitors 171
Recent developments in the field of adenosine receptor ligands. 169
Recent improvements in the development of A2B adenosine receptor agonists 168
Microwave-assisted synthesis of substituted 2,4-diarylthiazoles and their evaluation as anticancer agents 166
Hybrid molecules containing benzo[4,5]imidazo[1,2-d][1,2,4]thiadiazole and alpha-bromoacryloyl moieties as potent apoptosis inducers on human myeloid leukaemia cells 163
New 2-arylpyrazolo[4,3-c]quinoline derivatives as potent and selective human A(3) adenosine receptor antagonists 162
Pyrazolotriazolopyrimidine derivatives sensitize melanoma cells to the chemiotherapic drugs: taxol and vindesine. 161
New pyrrolo[2,1-f]purine-2,4-dione and imidazo[2,1-f]purine-2,4-dione derivatives as potent and selective human A(3) adenosine receptor antagonists 160
Recent improvements in the development of A2B adenosine receptor agonists 160
Recent developments in A2B adenosine receptor ligands 160
A structural study of new potent and selective antagonists to the A(2B) adenosine receptor 160
Recent developments in the field of A(2A) and A(3) adenosine receptor antagonists 158
Synthesis, radiolabeling, and preliminary biological evaluation of [H-3]-1-[(S)-N,O-bis-(isoquinolinesulfonyl)-N-methyl-tyrosyl]-4-(o-tolyl )-piperazine, a potent antagonist radioligand for the P2X(7) receptor 157
New synthesis of diazepino[3,2,1-ij]quinoline and pyrido[1,2,3-de] quinoxalines via addition-elimination followed by cycloacylation 157
New 2-arylpyrazolo[4,3-c]quinoline derivates as potent and selective human A3 adenosine receptor antagonists 157
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 156
Preparation of substituted purinylpyrazolylacetamides as adenosine A2B receptor antagonists. 156
Blockade of globus pallidus adenosine A2A receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D 1 or D2 dopamine receptor agonists 155
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 155
Design, synthesis, and biological evaluation of C-9- and C-2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c] pyrimidines as new A(2A) and A(3) adenosine receptors antagonists 154
Concise Synthesis and Biological Evaluation of 2-Aroyl-5-Amino Benzo[b]thiophene Derivatives As a Novel Class of Potent Antimitotic Agents 153
Synthesis and biological evaluation of novel N-6-[4-(substituted) sulfonamidophenylcarbamoyl]adenosine-5 '-uronamides as A(3) adenosine receptor agonists 152
Medicinal chemistry, pharmacology, and potential therapeutic benefits of cannabinoid CB2receptor agonists 152
New strategies for the synthesis of A(3) adenosine receptor antagonists 151
Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson's disease 148
MODULATION OF MMP-9 IN U87MG GLIOBLASTOMA CELLS BY A3 ADENOSINE RECEPTORS 148
Involvement of globus pallidus in the antiparkinsonian effects of adenosine A2A receptor antagonists 147
Structure-activity relationships of 2-amino-3-aroyl-4-[(4-arylpiperazin-1- yl)methyl]thiophenes. Part 2: Probing the influence of diverse substituents at the phenyl of the arylpiperazine moiety on allosteric enhancer activity at the A 1 adenosine receptor 143
Cytotoxic drugs regulate VEGF and IL-8 expression in human melanoma cells by A2A and A3 adenosine receptors. 142
Preparation of fused purine derivatives as adenosine A3 receptor modulators. 141
Allosteric enhancers of A1 adenosine receptors: State of the art and new horizons for drug development 141
Synthesis and biological evaluation of 2-substituted-4-(3 ',4 ',5 '-trimethoxyphenyl)-5-aryl thiazoles as anticancer agents 140
Recent developments in the field of adenosine receptor ligands 138
Preparation of fused purine derivatives as adenosine A3 receptor modulators. 135
Ligands for A(2B) adenosine receptor subtype 134
Modulation of MMP-9 in U87MG glioblastoma cells by A3 adenosine receptors. 134
Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine ligands, new tools to characterize A(3) adenosine receptors in human tumor cell lines 133
Recent improvements in the field of A(3) adenosine receptor ligands 133
New pyrrolo [2,1-f] purine-2,4-dione and Imidazo[2,1-f]purine-2,4-dione derivates as potent and selective human A3 adenosine receptor antagonists 132
Design, synthesis and biological evaluation of hybrid molecules containing conjugated styryl ketone and α-bromoacryloyl moieties 131
Role of strong intramolecular N-H...N hydrogen bonds in determining the conformation of adenosine-receptors antagonists 130
Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models. 129
Discovery of 1,5-Diphenylpyrazole-3-Carboxamide Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors 123
Totale 19.032
Salva come PNG Salva come JPEG
Categoria #
all - tutte 93.291
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.295
Totale 95.586
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.156 0 0 0 0 0 221 55 228 43 267 210 132
2021/20221.546 58 144 147 53 98 78 79 53 57 118 150 511
2022/20231.389 142 82 26 183 291 209 58 109 171 10 67 41
2023/2024752 67 94 43 28 56 111 38 74 13 10 11 207
2024/20253.165 65 101 246 128 370 336 120 189 405 315 474 416
2025/20265.782 906 586 1.351 1.112 1.268 559 0 0 0 0 0 0
Totale 23.704